Xeltis Hemodialysis Access Graft (aXess) US Study

Clinical trial NCT06494631 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06494631
Sponsor: Xeltis
Status: ENROLLING_BY_INVITATION
Phase: Not Applicable
Study type: INTERVENTIONAL

End Stage Renal Disease

Start date: 2024-11-11
Primary completion: 2028-01-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.